× Your free unusual options activity stream is delayed by a few hours. Select a subscription plan to access historical and intraday data.

Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company's other products under pipeline are SD-101, DV1179 Autoimmune Disease and AZD1419 Asthma Therapy. Dynavax Technologies was founded by Lawrence M. Lichtenstein, Dennis A. Carson and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

UOA Trade History
Loading...


Bullish Option Contracts

Dynavax Technologies Corp. call option contracts that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the upside



Loading...
Loading...

Bearish Option Contracts

Dynavax Technologies Corp. put option contracts that are bought on or above the market's asking price OR call option contracts that are sold on or less than the market's bid price - expecting a move to the downside



Loading...
Loading...
How To Trade DVAX Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Dynavax Technologies Corp.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.